Search

Author/Creator Guclu, Salih Zeki

1. A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS). (September 2016)

Authors:
Smit, Egbert F.; Wu, Yi-Long; Gervais, Radj; Zhou, Caicun; Felip, Enriqueta; Feng, Jifeng; Guclu, Salih Zeki; Hoiczyk, Mathias; Dorokhova, Elena; Freudensprung, Ulrich; Grange, Susan; Perez-Moreno, Pablo Diego; Mitchell, Lada; Reck, Martin
Journal:
Lung cancer
Issue:
Volume 99(2016)
Page Start:
94
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study. Issue 32 (10th November 2021)

Authors:
Ramalingam, Suresh S.; Novello, Silvia; Guclu, Salih Zeki; Bentsion, Dmitry; Zvirbule, Zanete; Szilasi, Maria; Bernabe, Reyes; Syrigos, Konstantinos; Byers, Lauren Averett; Clingan, Philip; Bar, Jair; Vokes, Everett E.; Govindan, Ramaswamy; Dunbar, Martin; Ansell, Peter; He, Lei; Huang, Xin; Sehg...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 32(2021)
Page Start:
3633
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search